CONSTATRE: Risperdal Consta Trial Of Relapse Prevention And Effectiveness.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2014
At a glance
- Drugs Risperidone (Primary) ; Aripiprazole; Quetiapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms CONSTATRE
- Sponsors Janssen-Cilag
- 08 Nov 2011 Cost of relapse results presented at the 14th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
- 01 Nov 2010 Primary endpoint results published in Neuropsychopharmacology
- 14 Jul 2009 Actual patient number changed from 710 to 753 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History